Package 33342-003-09

{"route": ["ORAL"], "spl_id": "c28a7cc4-0638-4fc2-a549-a87887e8d50e", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "upc": ["0333342003096"], "unii": ["2T8Q726O95", "4B9XT59T7S"], "rxcui": ["200082"], "spl_set_id": ["63667952-be01-483e-9887-1d5417e7ec16"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (33342-003-09)", "package_ndc": "33342-003-09", "marketing_start_date": "20180830"}], "brand_name": "Lamivudine and Zidovudine", "product_id": "33342-003_c28a7cc4-0638-4fc2-a549-a87887e8d50e", "dosage_form": "TABLET", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "33342-003", "generic_name": "Lamivudine and Zidovudine", "labeler_name": "Macleods Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamivudine and Zidovudine", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "150 mg/1"}, {"name": "ZIDOVUDINE", "strength": "300 mg/1"}], "application_number": "ANDA090679", "marketing_category": "ANDA", "marketing_start_date": "20180830", "listing_expiration_date": "20261231"}